FJFaranak Jamshidian

Faranak Jamshidian

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Faranak Jamshidian has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Identification of Critical miRNAs miR ‐4652 and miR ‐1304 as Novel Diagnostic Markers for Oral Squamous Cell Carcinoma

    by Sara Bagheri Farahani, Ehsan Keramati, Marziyeh Etesami, Faranak Jamshidian

    Background: Oral squamous cell carcinoma (OSCC) is marked by frequent recurrence rates and an unclear etiology, underscoring the critical need for early detection to improve therapeutic outcomes and reduce healthcare costs. MicroRNAs (miRNAs) have emerged as key regulators of oral carcinogenesis by modulating gene expression at the posttranscriptional level and influencing various aspects of cellular physiology. Objective: This study aimed to comprehensively evaluate the prognostic significance of miR‐1304 and miR‐4652 expression levels in patients with OSCC, and to explore their potential as predictive biomarkers for disease progression and patient survival. Methods: TargetScan was used to predict potential gene interactions of the microRNAs. Subsequently, the expression levels of C‐Myc and the microRNAs miR‐1304‐3p and miR‐4652‐5p were evaluated in 30 pairs of OSCC and adjacent normal tissue samples. qRT‐PCR analyses were performed to compare the expression of these molecules between tumor and normal tissues. Additionally, receiver operating characteristic (ROC) curves were generated to assess the potential diagnostic value of these microRNAs in OSCC. Result: The expression levels of miR‐1304, miR‐4652, and C‐Myc were significantly higher in OSCC tissues compared to their matched adjacent non‐tumor tissues ( p < 0.0001). Notably, high C‐Myc expression was significantly correlated with both tumor grade ( p = 0.003) and tumor stage ( p = 0.005). ROC curve analysis demonstrated that the areas under the curve (AUCs) for C‐Myc, hsa‐miR‐1304, and hsa‐miR‐4652 were 0.99, 0.99, and 0.95, respectively ( p < 0.0001), indicating strong diagnostic potential. Conclusion: These findings suggest that the upregulation of miR‐1304 and miR‐4652 could be used as biomarkers in OSCC. However, more studies with large samples are necessary.

  • Association Between miR-539 and miR-6824 and Their Target Gene, MAP2K1, Expression Level in Oral Cancer

    by Sara Bagheri Farahani, Farzaneh Jahangiri, Faranak Jamshidian, Hadise Mohammadpour

    Oral cancer affects millions of people with a high mortality rate throughout the world. Increasing evidences have demonstrated that mircoRNAs (miRNAs) play crucial roles in the modulation of tumour growth and progression, whereas the functional role of miR-539 and miR-6824 in oral cancer is not well established. The mitogen-activated protein kinase (MAPK) pathway has a master control role in various cancer-related biological processes as cell growth, proliferation, differentiation, migration, and apoptosis. Mitogen-activated protein kinase 1, also known as MAP2K1, was verified as the target of miR-539 and miR-6824. In our present study, we sought to explore biological role of miR-539 and miR-6824 in OSCC progression and for better specificity and efficiency; stem-loop primers followed by real‐time polymerase chain reaction have been determined. The expression level of miR-539 and miR-6824 expression was downregulated in OSCC tissues (p value = 0.00) (p value = 0.269) and OLP tissues (p value = 0.006) (p value = 0.054). Significant upregulation of MAP2K1 gene was noted in the OLP (p value = 0.034) and OSCC (p value = 0.01), specimens compared with healthy controls. Significant positive correlations were observed between miR-539 and miR-6824 (p value = 0.05). Receiver operating characteristic (ROC) curve analysis was performed to assess the sensitivity and specificity of miRNAs as diagnostic biomarkers and result showed area under the ROC curve (AUC) of map2k1 was 0.92, has_miR_539 the area under ROC curve (AUC) was of 0.982 (p = 0.0001) and has_miR_6824 was 1.000 (p < 0.0001). This study provides the first evidence of the miR-539 and miR-6824 role in oral cancer and suggests a potential therapeutic target and prognostic predictor for oral cancer.


  • Open Access

    CIRC-0008798 and CIRC-0035967 as novel biomarkers in oral lichen planus and oral squamous cell carcinoma

    by Sara Bagheri Farahani, Farzaneh Jahangiri, Faranak Jamshidian

    Emerging evidence has indicated that circRNAs, a novel class of endogenous noncoding RNAs formed by a covalently closed loop, play an important role in oral cancer. However, the role of circ-0008798 and circ-0035967 in oral cancer remains unclear. Oral cancer has been considered as one of the major leading causes of cancer-related mortality. It involves different mechanisms and signaling pathways such as a MAPK pathway that comprises several key signalling components and phosphorylation events in tumorigenesis. The purpose of this study is to investigate the expression profile of circRNA in oral cancer tissue and explore the regulatory mechanism in oral cancer tumorigenesis. the present study, qRT-PCR was used to detect the expression of circ-0008798, circ-0035967 and map2k1 in 30 pairs of samples of oral cancer tissue and adjacent normal tissue.Significant upregulation of MAP2K1 gene was noted in the OLP (p value = 0.034), and OSCC (p value = 0.00), specimens compared with healthy controls. The expression level of circ-008798 and circ-0035967 expression was down-regulated in OSCC tissues (p value = 0.23), (p value = 0.00) and OLP tissues (p value = 0.088), (p value = 0.054).Moreover, the area under ROC curves (AUC) ofmap2k1 was 0.92, has_circ_0008798 was 1.00 (p < 0.001) and has_circ_0035967 was 0.99 (p < 0.001). Our data may help researchers to predict the molecular mechanisms of novel circ-0008798 and circ-0035967 in the development and progression of oral cancer comprehensively. Moreover, the present data indicate that novel circ-0008798 and circ-0035967 targets may be a series of promising candidates as biomarkers for oral cancer.

  • Open Access

    The possibility of early diagnosis of colorectal cancer through expression of Lncrna UCA1, Lncrna LINC00970, and Wnt genes; an in-vitro study

    by Seyedeh Medisa Sadat Razavi, Narges Maleki, Faranak Jamshidian

    Colorectal cancer is the 4th cause of cancer death; with considering the growth process of this cancer and the necessity of early diagnosis, the purpose of the research is to state the LncRNA 00970, LncRNA UCAI, and the Wnt gene before and after the treatment by 5-Azacytidine epigenetic medicine, to reach the biomarker in the very first steps of colorectal cancer. In this experiment, the human colon cancer cell line (HT29) treated with different concentrations of 5-aza-2’-deoxycytidine (5-aza-dC) was utilized to induce DNA demethylation; Quantitative PCR (qPCR) was used to measure LncRNA UCA1 and LncRNA LINC00970 and Wnt expression. There was a significant relationship between the expression of LncRNA 00970, LncRNA UCAI, and the Wnt gene and its effects on colorectal (p < 0.05). The Wnt gene was treated by 1 and 10 of 5-Azacytidine epigenetic medicine, which then experienced decreases. In LncRNA UCAI and LncRNA00970 in dose 1 micromolar of 5-Azacytidine had decrement and increment of expression respectively that explains their efficiency but in treatment by dose 10 mM of this medicine, no significant LncRNA expression difference was detected, 5-azacitidine has a direct impact on its target genes and LncRNAs. Therefore, it can be used in the early diagnosis of colorectal cancer.